Could $150 Oil Be Realistic Three Weeks From Now? In Markets
Analysts warn that a spike to $150 oil within two to three weeks is a risk scenario, not a forecast, but markets are ...
Which Is Better Index Fund Or Active Fund
Assess which is better for you: index funds or active funds, focusing on costs, performance consistency, and your investment horizon.
24,613 articlesStock Market Today, June: AI Financing Shifts Fulfillment Focus
Investors weigh a massive AI financing move and its impact on a major server maker’s backlog. This piece explains wha...
Goldman Sachs Says Spacex Could Hit $474B by 2030: AI Winners
A daring forecast from Goldman Sachs imagines SpaceX turning into a multi-hundred-billion-dollar revenue machine by 2...
Ukrainian Drones Target More Russian Oil Infrastructure
A weekend wave of strikes targeted Russian oil terminals, including in St. Petersburg, intensifying a fuel squeeze an...
Lattice Semiconductor Ford Tamer: Investor Insights
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Oil Hits $100 These Energy Dividends Stand Out Today
Oil edges toward a $100 threshold as geopolitical tensions intensify. Four key energy names—Exxon, Chevron, ConocoPhi...
Surf Mobility Earnings: SRFM Earnings Outlook and Analysis
This article breaks down surf mobility (SRFM) earnings in plain language. Learn what the SRFM earnings transcript rev...
JPMorgan Analyst Tempts Scott with Oil Shortage Forecast
A JPMorgan analyst forecasts looming oil shortages within weeks, drawing a sharp response from investors and fund man...
Should Micron Technology Stock Be Bought Now or Dip?
Memory-chip demand has surged with AI and cloud growth, but timing still matters. This guide breaks down how to evalu...
Stock Split Watch: Lilly — Is Eli Lilly Next to Split?
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status